Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Longitude Capital
AddedFeb 13, 2024
UpdatedJul 16, 2026
Longitude Capital

Longitude Capital

Operating

Longitude Capital: A venture capital firm investing in biotech, medtech, and health solutions for improved life quality.

Location
Menlo Park, CA, US
Founded
2006
Firm
Compare
Portfolio
Employees
Website

Longitude Capital is a venture capital firm that specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies. The firm focuses on improving clinical outcomes, enhancing patient quality of life, and reducing the cost of care. Longitude Capital invests in both privately held and publicly traded companies, participating in various investment rounds including Series A, B, C, and beyond.

Notable portfolio companies include Alphaeon, Amphora Medical, Aptinyx, and Somatus. Key partners and decision-makers at Longitude Capital bring extensive experience from leading healthcare and investment firms. The firm’s investment philosophy centers on identifying transformative healthcare innovations. Additionally, Longitude Capital offers unique value-add services to its portfolio companies, leveraging its deep industry expertise and network to support growth and strategic development.

Longitude Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments65
Current Portfolio Count37
Total Portfolio Exits1

Top Investment Stages

Series B17 (34.0%)
Series A12 (24.0%)
Series C9 (18.0%)
Series Unknown7 (14.0%)
Private Equity5 (10.0%)

Stage Mix

Series B 34%Series A 24%Series C 18%Series Unknown 14%Private Equity 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Cohere Health logo

Cohere Health

Nalu Medical logo

Nalu Medical

Lassen Therapeutics logo

Lassen Therapeutics

OrsoBio logo

OrsoBio

Quanta Therapeutics logo

Quanta Therapeutics

Cortica logo

Cortica

Nocd logo

Nocd

Rivus Pharmaceuticals logo

Rivus Pharmaceuticals

IntelyCare logo

IntelyCare

Somatus logo

Somatus

Endeavor Biomedicines logo

Endeavor Biomedicines

Avenge Bio logo

Avenge Bio

Sydnexis logo

Sydnexis

Ceribell logo

Ceribell

Polares logo

Polares

Rapid Micro Biosystems logo

Rapid Micro Biosystems

Dascena logo

Dascena

Epirium Bio logo

Epirium Bio

Poseida Therapeutics logo

Poseida Therapeutics

Encore Dermatology logo

Encore Dermatology

Tiburio Therapeutics logo

Tiburio Therapeutics

CuraSen Therapeutics logo

CuraSen Therapeutics

Velicept Therapeutics logo

Velicept Therapeutics

Murj logo

Murj

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

Longitude Capital - Similar Investment Firms

Longwood Fund logo

Longwood Fund

longwoodfund.com

Longevity Vision Fund logo

Longevity Vision Fund

longevity.vision

Longley Capital logo

Longley Capital

longleycapital.com

The Longevity Fund logo

The Longevity Fund

longevity.vc

LongeVC logo

LongeVC

longevc.com

Long Venture Partners logo

Long Venture Partners

longvp.com

Lux Capital logo

Lux Capital

luxcapital.com

Long Arc Capital logo

Long Arc Capital

longarc.com

Longevity Venture Partners logo

Longevity Venture Partners

Aphelion Capital logo

Aphelion Capital

Healthspan Capital logo

Healthspan Capital

Lightstone Ventures logo

Lightstone Ventures

lightstonevc.com

Bioventures Investors logo

Bioventures Investors

Continuum Health Ventures logo

Continuum Health Ventures

continuumhealth.vc

LongShot Capital logo

LongShot Capital

longshotcap.com

Longitude Capital - Classification

Also Known As
  • Longitude Capital Management Co., LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
ISIC
  • 6430Trusts, funds and similar financial entities
Show 9 more industry codes
NAICS
  • 525900Other Investment Pools and Funds
  • 525990Other Financial Vehicles
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6726Unit Investment Trusts, Face-amount Certificate Offices
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end